July 29, 2020 06:57 AM EDTUpdated July 30, 11:23 AM
News Briefing

Trump, Big Phar­ma trade barbs over drug pric­ing EOs; BAR­DA gives Re­gen­eron $350M for Ebo­la drugs

Max Gelman

Senior Editor

Jason Mast

Editor

Ten­sions be­tween the White House and Big Phar­ma have ratch­eted up af­ter Pres­i­dent Don­ald Trump an­nounced four ex­ec­u­tive or­ders tar­get­ing the phar­ma­ceu­ti­cal in­dus­try. On …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times